Stephen E. Karp
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Genetics 9
- Virus-based gene therapy research 5
- BRCA gene mutations in cancer 4
-
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 3
- Co-authors
- William D. Foulkes (3 shared papers)Steven A. Rosenberg (4 shared papers)Nicholas P. Restifo (4 shared papers)James J. Mulé (4 shared papers)Stephen Calabro (1 shared paper)W. Marston Linehan (1 shared paper)Donald E. White (1 shared paper)Michael T. Lotze (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)The Journal of Immunology (2 papers)Cancer (2 papers)Human Gene Therapy (2 papers)Journal of Surgical Oncology (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Stephen E. Karp
23 papers receiving 2.2k citations
Stephen E. Karp's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 878
- Immunology 539
- Oncology 645
- Genetics 549
- Immunology and Allergy 109
Countries citing papers authored by Stephen E. Karp
This map shows the geographic impact of Stephen E. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Karp more than expected).
Fields of papers citing papers by Stephen E. Karp
This network shows the impact of papers produced by Stephen E. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Karp. The network helps show where Stephen E. Karp may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Karp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study Hit paper breakdown → | 2014 | 585 |
| 2 | Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor Hit paper breakdown → | 1994 | 517 |
| 3 | 1989 | 317 | |
| 4 | The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. | 2001 | 172 |
| 5 | 1992 | 145 | |
| 6 | 1997 | 139 | |
| 7 | Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. | 1997 | 97 |
| 8 | 1993 | 72 | |
| 9 | 1999 | 61 | |
| 10 | 1992 | 38 | |
| 11 | 1995 | 35 | |
| 12 | 1992 | 23 | |
| 13 | 1993 | 23 | |
| 14 | 2003 | 21 | |
| 15 | 1998 | 12 | |
| 16 | 2000 | 10 | |
| 17 | 2000 | 8 | |
| 18 | 1997 | 8 | |
| 19 | 2007 | 4 | |
| 20 | 2013 | 3 |
About Stephen E. Karp
Stephen E. Karp is a scholar working on Genetics, Immunology, Oncology, Cancer Research and Molecular Biology, having authored 23 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Breast Cancer Treatment Studies (6 papers), Virus-based gene therapy research (5 papers), BRCA gene mutations in cancer (4 papers), Cancer Research and Treatments (4 papers), RNA Interference and Gene Delivery (3 papers), Immune Cell Function and Interaction (3 papers) and Breast Lesions and Carcinomas (3 papers). The work is most often cited by research in Cancer Research (878 citations), Immunology (539 citations), Oncology (645 citations), Genetics (549 citations) and Immunology and Allergy (109 citations). Stephen E. Karp has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include William D. Foulkes, Steven A. Rosenberg, Nicholas P. Restifo, James J. Mulé, Stephen Calabro, W. Marston Linehan, Donald E. White, Michael T. Lotze, Seth M. Steinberg and Jiacai Yang. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology, Cancer, Human Gene Therapy and Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.